4//SEC Filing
Toernsen Monika Maria 4
Accession 0001209191-21-047616
CIK 0001787297other
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 6:54 PM ET
Size
8.2 KB
Accession
0001209191-21-047616
Insider Transaction Report
Form 4
Toernsen Monika Maria
Chief Commercial Officer
Transactions
- Award
Restricted Stock Units
2021-07-19+20,000→ 20,000 total→ Common Stock (20,000 underlying) - Award
Employee Stock Option (Right to Buy)
2021-07-19+200,000→ 200,000 totalExercise: $13.04Exp: 2031-07-18→ Common Stock (200,000 underlying)
Footnotes (3)
- [F1]The option vests as to 25% of the total shares on July 19, 2022, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on July 19, 2024, subject to the Reporting Person's provision of service to the issuer on each vesting date.
- [F2]Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
- [F3]1/4 of the RSUs will vest annually on September 15, 2022, and the remainder will vest as to 1/4 of the total award in annual installments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date.
Documents
Issuer
Passage BIO, Inc.
CIK 0001787297
Entity typeother
Related Parties
1- filerCIK 0001873385
Filing Metadata
- Form type
- 4
- Filed
- Jul 20, 8:00 PM ET
- Accepted
- Jul 21, 6:54 PM ET
- Size
- 8.2 KB